Episode
This Fortnight in Medicine XXV
- Podcast
- Sensible Medicine
- Published
- May 6, 2026
- Duration seconds
- 1820
- Processing state
not_requested- Canonical source
- https://www.sensible-med.com/p/this-fortnight-in-medicine-xxv
Actions
POST https://stenobird.com/v1/public/podcasts/sensible-medicine-5998897/episodes/this-fortnight-in-medicine-xxv/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/sensible-medicine-5998897/this-fortnight-in-medicine-xxv.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients * Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage * Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe